GIANT CELL ARTERITIS

Clinical trials for GIANT CELL ARTERITIS explained in plain language.

Never miss a new study

Get alerted when new GIANT CELL ARTERITIS trials appear

Sign up with your email to follow new studies for GIANT CELL ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 13 Not yet recruiting 2 Not yet finished but already full! 4 Completed 6 Terminated 1

Could an arthritis drug tame giant cell arteritis?

Disease control Terminated

This study tested whether adding anakinra, an anti-inflammatory drug, to standard steroid treatment could lower relapse rates in people with giant cell arteritis, a blood vessel disease. The trial planned to include 70 adults over 50 but was stopped early with only 30 participant…

Matched conditions: GIANT CELL ARTERITIS

Phase: PHASE3 • Sponsor: University Hospital, Caen • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

GIANT CELL ARTERITIS

Get alerted when new GIANT CELL ARTERITIS trials appear

Could an arthritis drug tame giant cell arteritis?